Support teaching, research, and patient care.
Dr. Fredericson is the first physician promoted to Professor of Physical Medicine & Rehabilitation (PM&R) at Stanford University and is currently Director of PM&R Sports Medicine in the Department of Orthopaedic Surgery, Co-Director of the Stanford Longevity Center, and Founder of Lifestyle Medicine (https://longevity.stanford.edu/lifestyle/lifestyle-medicine-2/). He is also the Head Team Physician for the Stanford Track & Field and Swimming Teams, the Medical Director for Stanford Club Sports, and a Wu Tsai Human Performance Alliance member. In addition, he has volunteered at both a national and international level with USA Track & Field and the International Olympic Committee.Dr. Fredericson has been a featured speaker at numerous national and international sports medicine and rehabilitation symposiums and Visiting Professor at many institutions around the country. He has published over 215 peer-reviewed articles, 40 book chapters, and five books focused on an improved understanding and treatment strategies for overuse injuries in athletes. He is currently on the Men's Health Magazine Advisory Board and has also held several scientific editorial appointments, among which are senior founding editor, PM&R, the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (2007 to 2014); associate editor, Clinical Journal of Sports Medicine (1999 to 2004); and editorial board member, Physician and Sports Medicine (1996 to 1999) and associate editor of the textbook, Essentials of Physical Medicine and Rehabilitation, 4rd Edition. He has also served as Co-Chairman of the Research Task Force for the Sports Medicine and Exercise Science Committee of USA Track & Field and has been honored with several prestigious grants from the Pac-12 Conference Student-Athlete Health & Well-Being Grant Program. His work's impact is widely recognized: he is listed on ResearchGate as one of their top-cited researchers (99th percentile). He is also frequently featured in national and international media and lay publications, with over 250 interviews for his expertise on a wide range of sports medicine, fitness, and health promotion topics.Dr. Fredericson created the first ACGME Sports Medicine Fellowship at Stanford University and continues as Fellowship Director. He has received various honors, including the American Academy of PM&R PASSOR Mid-Career Legacy Award and the 2023 Distinguished Member Award, for his efforts to develop and foster musculoskeletal education and research for medical students, residents, and fellows. He founded several programs, including Lifestyle Medicine and Sports Medicine courses for Stanford medical and undergraduates, a monthly orthopedic consultation service at the Stanford Arbor Free Clinic, the Stanford RunSafe Injury Prevention Program, and Lifestyle Medicine Program. For the past 20 years, he has also offered an international research fellowship in sports medicine with participation from physicians worldwide, including Switzerland, South Korea, Spain, Singapore, Brazil, France, China, and Japan. As a result of this experience, many of these physicians have been promoted to major sports medicine and academic appointments in their home countries.
American Board of Family Practice
My research focuses on the etiology, prevention, and treatment of overuse sports injuries in athletes and lifestyle medicine practices for improved health and longevity.
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
This study assesses the potential benefit of adjuvant platelet-rich plasma (PRP) with carpal
tunnel release (CTR) for patients with severe carpal tunnel syndrome (CTS). CTR is a rather
common procedure performed and seems to be quite effective for those with moderate CTS, but a
number of patients with severe CTS do not have quite the same response post-CTR. The
investigators will recruit patients who fall into the severe CTS category and compare CTR
with and without adjuvant PRP to see if PRP can improve outcomes of this common surgery.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details